SCHEMBL20067129

SCHEMBL20067129

Cc1ccc2c(c1)Nc1ccccc1C=N2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.43
ALDH1A1 P00352 3/20 0.43
RAB9A P51151 2/20 0.43
KDM4E B2RXH2 2/20 0.43
NPC1 O15118 1/20 0.43
GAA P10253 2/20 0.42
HTT P42858 1/20 0.42
CSNK1G1 Q9HCP0 1/20 0.41
MAPT P10636 4/20 0.39
ROS1 P08922 1/20 0.39
CDK5 Q00535 1/20 0.39
ACVR1 Q04771 1/20 0.39
LRRK2 Q5S007 1/20 0.39
TP53 P04637 2/20 0.35
TRPA1 O75762 3/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
USP2 O75604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20067130 0.87 CSNK1G1 (0.41) SMN1; SMN2ALDH1A1RAB9AKDM4ENPC1
SCHEMBL20067134 0.87 ROS1 (0.42) SMN1; SMN2ALDH1A1RAB9AKDM4ENPC1
SCHEMBL8204921 0.81 MAPT (0.41) SMN1; SMN2ALDH1A1KDM4EGAAMAPT
SCHEMBL7456203 0.80 TRPA1 (0.43) GAAMAPTTP53TRPA1MEN1
SCHEMBL309794 0.80 MAPT (0.50) SMN1; SMN2ALDH1A1KDM4EGAAMAPT
SCHEMBL20067137 0.76 TRPA1 (0.47) GAAMAPTTRPA1
SCHEMBL8203046 0.75 GAA (0.41) GAAMAPTTRPA1MEN1KMT2A
SCHEMBL20067132 0.74 MAPT (0.50) ALDH1A1RAB9ANPC1HTTMAPT
SCHEMBL4673880 0.74 TRPA1 (0.58) SMN1; SMN2ALDH1A1KDM4EHTTMAPT
SCHEMBL30285272 0.73 MAPT (0.64) SMN1; SMN2ALDH1A1RAB9AKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3310765-B1 PROCESS FOR PREPARING 1,4-DIBENZODIAZEPINES VIA BUCHWALD-HARTWIG CHEMISTRY UNIV EVORA (PT) 2019-06-12 EP disclosed
US-10208001-B2 Process for preparing 1,4-dibenzodiazepines via Buchwald-Hartwig chemistry UNIVERSIDADE DE EVORA (PT) 2019-02-19 US disclosed
US-20180105502-A1 PROCESS FOR PREPARING 1,4-DIBENZODIAZEPINES VIA BUCHWALD-HARTWIG CHEMISTRY UNIVERSIDADE DE EVORA (PT) 2018-04-19 US disclosed
US-20180105502-A1 PROCESS FOR PREPARING 1,4-DIBENZODIAZEPINES VIA BUCHWALD-HARTWIG CHEMISTRY UNIVERSIDADE DE EVORA (PT) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10208001-B2 Process for preparing 1,4-dibenzodiazepines via Buchwald-Hartwig chemistry HRH2, HRH4, HRH1 SMN1; SMN2 3533/4885ALDH1A1 235/4885RAB9A 1993/4885
US-20180105502-A1 PROCESS FOR PREPARING 1,4-DIBENZODIAZEPINES VIA BUCHWALD-HARTWIG CHEMISTRY HRH2, HRH4, HRH1 SMN1; SMN2 3533/4885ALDH1A1 235/4885RAB9A 1993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.